The
global obesity treatment market is expected to reach USD 15.6 billion by 2024,
according to a new report by Grand View Research, Inc. Upward trend in
sedentary lifestyles, physical inactivity, and unhealthy food habits are the
vital factors responsible for the high prevalence of obesity. According to the
Institute of Health Metrics and Evaluation, about 30.0% of the global
population is either obese or overweight.
Additionally,
along with commercial availability of solutions for weight management, technological
advancements introduced by the vertical players and supportive initiatives
undertaken by the governments, create more awareness with regard to obesity and
its impact on health. This is further driving the growth of the obesity
treatment market.
There
are various approaches for weight management such as diet, exercise, drugs,
minimally invasive devices & implants, and surgeries. Amongst the prevalent
drugs, the combination drugs hold the largest market share whereas satiety
drugs that provide a feeling of fullness appear as the fastest growing segment
in the obesity treatment market.
In
surgeries, gastric bypass procedures form the largest growing segment whereas
the minimally invasive endoscopic procedure segment that involves surgical
placement of implants and devices, such as satiety devices and gastric empting
devices, is the fastest growing space.
Intense
competition in the private sector has driven advancements and innovation toward
the development of the latest techniques for obesity treatment that are offered
in private hospitals and clinics. As a result, the demand for minimally
invasive procedures is swiftly increasing. In addition, increasing awareness of
obesity & the associated diseases and the commercial availability of weight
management solutions is propelling the obesity treatment market.
In depth research report on Obesity Treatment Market
http://www.grandviewresearch.com/industry-analysis/obesity-treatment-devices-and-therapeutics-market
Further key findings from the study suggest:
·
The combination drugs segment
for obesity captured the largest market share of around 53% of the global
market in 2015. The largest share of the segment was mainly attributed to the
rising prevalence of obesity and the synergistic effect of combination therapy
in weight management.
·
In the surgeries and devices
segment, gastric bypass is the largest growing with a market share of over 32%,
while the minimally invasive endoscopic procedures segment is anticipated to be
the fastest growing category in obesity treatment for the forecast period
·
North America accounts for the
largest market share of around 52.0% in 2015. This region is expected to
maintain its dominance throughout the forecast period due to the heavy R&D
investments deployed to develop effective weight management solutions and the
commercial availability of minimally invasive procedures.
·
Asia Pacific is anticipated to
witness the fastest growth during the forecast period. Growing awareness of
adverse health effects related to excess weight and its impact amongst
individuals, rising disposable income, improving healthcare infrastructure, and
the emerging medical tourism industry are some of the factors expected to drive
the growth of the Asia Pacific sector during the forecast period.
·
Some key market participants
include VIVUS, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd.,
Novo Nordisk A/S, Allergan Plc, Medtronic, Ethicon (subsidiary of Johnson &
Johnson), Cousin Biotech, EnteroMedics, Inc., and USGI Medical, Inc.
·
The players are focusing on
product innovation through extensive R&D activities and introducing new
combination drugs & satiety products. In addition, the sector giants are
developing minimally invasive procedures and initiating collaborations to
expand their geographical territories to gain greater market presence.
Grand View Research has segmented the obesity
treatment market on the basis of product, application, and geography.
Global
Obesity Treatment Market Drugs Outlook (Revenue, USD Million, 2013 - 2024)
·
Combination Drugs
·
Appetite Suppressants
·
Malabsorption
·
Satiety
Global
Obesity Treatment Market Surgery & Devices Outlook (Revenue, USD Million,
2013 - 2024)
·
Adjusting Gastric Banding
·
Roux-en-Y Gastric Bypass
·
Sleeve Gastrectomy
·
Biliopancreatic Diversion With
Duodenal Switch
·
Endoscopic Procedures
·
Others
Obesity
Treatment Market Regional Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment